Terms: = Leukemia AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874 AND Diagnosis
134 results:
1. Differentiation syndrome associated with treatment with idh2 inhibitor enasidenib: pooled analysis from clinical trials.
Montesinos P; Fathi AT; de Botton S; Stein EM; Zeidan AM; Zhu Y; Prebet T; Vigil CE; Bluemmert I; Yu X; DiNardo CD
Blood Adv; 2024 May; 8(10):2509-2519. PubMed ID: 38507688
[TBL] [Abstract] [Full Text] [Related]
2. Reduced duration and dosage of venetoclax is efficient in newly diagnosed patients with acute myeloid leukemia.
Cui J; Chen X; Li C; Yan Q; Yuan G
Hematology; 2024 Dec; 29(1):2293512. PubMed ID: 38095287
[TBL] [Abstract] [Full Text] [Related]
3. [Effect of clonal hematopoiesis in remission on hematopoiesis recovery in patients with NPM1 mutated acute myeloid leukemia after chemotherapy].
Wang LL; Chen SN
Zhonghua Xue Ye Xue Za Zhi; 2023 Oct; 44(10):845-850. PubMed ID: 38049337
[No Abstract] [Full Text] [Related]
4. Test Then Erase? Current Status and Future Opportunities for Measurable Residual Disease Testing in Acute Myeloid leukemia.
Blackmon AL; Hourigan CS
Acta Haematol; 2024; 147(2):133-146. PubMed ID: 38035547
[TBL] [Abstract] [Full Text] [Related]
5. A comparative safety review of targeted therapies for acute myeloid leukemia.
Dalgetty M; Leurinda C; Cortes J
Expert Opin Drug Saf; 2023; 22(12):1225-1236. PubMed ID: 38014918
[TBL] [Abstract] [Full Text] [Related]
6. [Analysis of
Cui M; Li QY; Lu XZ; Chao HY; Cai XH; Liu J; Hua HY; Wu P
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1019-1025. PubMed ID: 37551471
[TBL] [Abstract] [Full Text] [Related]
7. Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm.
Tefferi A; Alkhateeb H; Gangat N
Blood Cancer J; 2023 Jul; 13(1):108. PubMed ID: 37460550
[TBL] [Abstract] [Full Text] [Related]
8. Progression in Myeloid Neoplasms: Beyond the Myeloblast.
Faria C; Tzankov A
Pathobiology; 2024; 91(1):55-75. PubMed ID: 37232015
[TBL] [Abstract] [Full Text] [Related]
9. Therapies for acute myeloid leukemia in patients ineligible for standard induction chemotherapy: a systematic review.
Heuser M; Fernandez C; Hauch O; Klibanov OM; Chaudhary T; Rives V
Future Oncol; 2023 Apr; 19(11):789-810. PubMed ID: 37170899
[TBL] [Abstract] [Full Text] [Related]
10. Older Adults With Newly Diagnosed AML: Hot Topics for the Practicing Clinician.
Lai C; Bhansali RS; Kuo EJ; Mannis G; Lin RJ
Am Soc Clin Oncol Educ Book; 2023 May; 43():e390018. PubMed ID: 37155946
[TBL] [Abstract] [Full Text] [Related]
11. Factors predicting survival following alloSCT in patients with therapy-related AML and MDS: a multicenter study.
Baranwal A; Chhetri R; Yeung D; Clark M; Shah S; Litzow MR; Hogan WJ; Mangaonkar A; Alkhateeb HB; Singhal D; Cibich A; Bardy P; Kok CH; Hiwase DK; Shah MV
Bone Marrow Transplant; 2023 Jul; 58(7):769-776. PubMed ID: 37012415
[TBL] [Abstract] [Full Text] [Related]
12. The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia.
Chen X; Tian C; Hao Z; Pan L; Hong M; Wei W; Muyey DM; Wang H; Chen X
Cancer Med; 2023 May; 12(9):10340-10350. PubMed ID: 36912186
[TBL] [Abstract] [Full Text] [Related]
13. Gene Mutations and Targeted Therapies of Myeloid Sarcoma.
Fu L; Zhang Z; Chen Z; Fu J; Hong P; Feng W
Curr Treat Options Oncol; 2023 Apr; 24(4):338-352. PubMed ID: 36877373
[TBL] [Abstract] [Full Text] [Related]
14. Single-center, observational study of AML/MDS-EB with idh1/2 mutations: genetic profile, immunophenotypes, mutational kinetics and outcomes.
Papadopoulou V; Schoumans J; Basset V; Solly F; Pasquier J; Blum S; Spertini O
Hematology; 2023 Dec; 28(1):2180704. PubMed ID: 36815747
[TBL] [Abstract] [Full Text] [Related]
15. Correlation of blood cell counts with mutant subtypes and impact prognosis in acute myeloid leukemia patients with FLT3 mutations.
Chen Y; Xie Y; Fang Y; Hong M; Shi J; Qian S
Hematology; 2023 Dec; 28(1):2172296. PubMed ID: 36738279
[TBL] [Abstract] [Full Text] [Related]
16. Significance of Gene diagnosis in Acute Myeloid leukemia with the Emergence of New Molecular Target Drug Treatment.
Yamaguchi H
J Nippon Med Sch; 2022; 89(5):470-478. PubMed ID: 36351633
[TBL] [Abstract] [Full Text] [Related]
17. Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations.
Ball S; Knepper TC; Deutsch YE; Samra W; Watts JM; Bradley TJ; Chan O; Hussaini MO; Zhang L; Sweet KL; Kuykendall AT; Talati C; Padron E; Komrokji RS; Lancet JE; Sallman DA
Cancer; 2022 Nov; 128(21):3880-3887. PubMed ID: 36107670
[TBL] [Abstract] [Full Text] [Related]
18. Impact of idh1 and idh2 mutational subgroups in AML patients after allogeneic stem cell transplantation.
Kunadt D; Stasik S; Metzeler KH; Röllig C; Schliemann C; Greif PA; Spiekermann K; Rothenberg-Thurley M; Krug U; Braess J; Krämer A; Hochhaus A; Scholl S; Hilgendorf I; Brümmendorf TH; Jost E; Steffen B; Bug G; Einsele H; Görlich D; Sauerland C; Schäfer-Eckart K; Krause SW; Hänel M; Hanoun M; Kaufmann M; Wörmann B; Kramer M; Sockel K; Egger-Heidrich K; Herold T; Ehninger G; Burchert A; Platzbecker U; Berdel WE; Müller-Tidow C; Hiddemann W; Serve H; Stelljes M; Baldus CD; Neubauer A; Schetelig J; Thiede C; Bornhäuser M; Middeke JM; Stölzel F;
J Hematol Oncol; 2022 Sep; 15(1):126. PubMed ID: 36064577
[TBL] [Abstract] [Full Text] [Related]
19. diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
Döhner H; Wei AH; Appelbaum FR; Craddock C; DiNardo CD; Dombret H; Ebert BL; Fenaux P; Godley LA; Hasserjian RP; Larson RA; Levine RL; Miyazaki Y; Niederwieser D; Ossenkoppele G; Röllig C; Sierra J; Stein EM; Tallman MS; Tien HF; Wang J; Wierzbowska A; Löwenberg B
Blood; 2022 Sep; 140(12):1345-1377. PubMed ID: 35797463
[TBL] [Abstract] [Full Text] [Related]
20. Incidental discovery of acute myeloid leukemia during liquid biopsy of a lung cancer patient.
Nkosi D; Miller CA; Jajosky AN; Oltvai ZN
Cold Spring Harb Mol Case Stud; 2022 Jun; 8(4):. PubMed ID: 35732498
[TBL] [Abstract] [Full Text] [Related]
[Next]